Mescher MF - Search Results

1

Activation-induced nonresponsiveness: a Th-dependent regulatory checkpoint in the CTL response.

Tham EL, Shrikant P, Mescher MF. Tham EL, et al. Among authors: mescher mf. J Immunol. 2002 Feb 1;168(3):1190-7. doi: 10.4049/jimmunol.168.3.1190. J Immunol. 2002. PMID: 11801654

2

Opposing effects of IL-2 in tumor immunotherapy: promoting CD8 T cell growth and inducing apoptosis.

Shrikant P, Mescher MF. Shrikant P, et al. Among authors: mescher mf. J Immunol. 2002 Aug 15;169(4):1753-9. doi: 10.4049/jimmunol.169.4.1753. J Immunol. 2002. PMID: 12165496

3

The poststimulation program of CD4 versus CD8 T cells (death versus activation-induced nonresponsiveness).

Tham EL, Mescher MF. Tham EL, et al. Among authors: mescher mf. J Immunol. 2002 Aug 15;169(4):1822-8. doi: 10.4049/jimmunol.169.4.1822. J Immunol. 2002. PMID: 12165505

4

In vivo augmentation of tumor-specific CTL responses by class I/peptide antigen complexes on microspheres (large multivalent immunogen).

Goldberg J, Shrikant P, Mescher MF. Goldberg J, et al. Among authors: mescher mf. J Immunol. 2003 Jan 1;170(1):228-35. doi: 10.4049/jimmunol.170.1.228. J Immunol. 2003. PMID: 12496404

5

Control of syngeneic tumor growth by activation of CD8+ T cells: efficacy is limited by migration away from the site and induction of nonresponsiveness.

Shrikant P, Mescher MF. Shrikant P, et al. Among authors: mescher mf. J Immunol. 1999 Mar 1;162(5):2858-66. J Immunol. 1999. PMID: 10072534

6

Signaling alterations in activation-induced nonresponsive CD8 T cells.

Tham EL, Mescher MF. Tham EL, et al. Among authors: mescher mf. J Immunol. 2001 Aug 15;167(4):2040-8. doi: 10.4049/jimmunol.167.4.2040. J Immunol. 2001. PMID: 11489986

7

CTLA-4 blockade reverses CD8+ T cell tolerance to tumor by a CD4+ T cell- and IL-2-dependent mechanism.

Shrikant P, Khoruts A, Mescher MF. Shrikant P, et al. Among authors: mescher mf. Immunity. 1999 Oct;11(4):483-93. doi: 10.1016/s1074-7613(00)80123-5. Immunity. 1999. PMID: 10549630 Free article.

8

Activation of antigen-specific T cells by artificial cell constructs having immobilized multimeric peptide-class I complexes and recombinant B7-Fc proteins.

Tham EL, Jensen PL, Mescher MF. Tham EL, et al. Among authors: mescher mf. J Immunol Methods. 2001 Mar 1;249(1-2):111-9. doi: 10.1016/s0022-1759(00)00335-5. J Immunol Methods. 2001. PMID: 11226469

9

The roles of IL-12 in providing a third signal for clonal expansion of naive CD8 T cells.

Valenzuela J, Schmidt C, Mescher M. Valenzuela J, et al. J Immunol. 2002 Dec 15;169(12):6842-9. doi: 10.4049/jimmunol.169.12.6842. J Immunol. 2002. PMID: 12471116

10

CD8 T cell clonal expansion and development of effector function require prolonged exposure to antigen, costimulation, and signal 3 cytokine.

Curtsinger JM, Johnson CM, Mescher MF. Curtsinger JM, et al. Among authors: mescher mf. J Immunol. 2003 Nov 15;171(10):5165-71. doi: 10.4049/jimmunol.171.10.5165. J Immunol. 2003. PMID: 14607916

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

145 results

Search Page

Filters